Rho-associated kinase (ROCK) function is essential for cell cycle progression, senescence and tumorigenesis

Sandra Kümper1, Faraz K Mardakheh1, Afshan McCarthy1

  • 1Division of Cancer Biology, Institute of Cancer Research, London, United Kingdom.

Elife
|January 15, 2016
PubMed

Insights

Rho-associated kinases (ROCK1/2) maintain cell proliferation and actomyosin contractility. Their combined loss halts cell-cycle progression and blocks tumor formation in cancer models.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Rho-associated kinases (ROCK1/2) are key regulators of the actin cytoskeleton.
  • Their specific roles in cell proliferation and cancer development remain largely uncharacterized.

Purpose of the Study:

  • To investigate the function of ROCK1 and ROCK2 in cell proliferation and tumorigenesis.
  • To elucidate the molecular mechanisms underlying ROCK's role in cancer initiation and progression.

Main Methods:

  • Utilized mouse models of non-small cell lung cancer and melanoma.
  • Performed genetic deletion of Rock1 and Rock2, individually and concurrently.
  • Analyzed cell-cycle progression, cellular senescence, and expression of key cell-cycle proteins (CyclinA, CKS1, CDK1).

Main Results:

  • ROCK1 and ROCK2 act redundantly to maintain actomyosin contractility and support cell proliferation.
  • Loss of both ROCK1 and ROCK2 induces cell-cycle arrest and cellular senescence.
  • Down-regulation of CyclinA, CKS1, and CDK1 was observed upon ROCK loss.
  • Simultaneous genetic deletion of Rock1 and Rock2 completely inhibited tumor formation in cancer models.

Conclusions:

  • ROCK1 and ROCK2 play indispensable, yet redundant, roles in cell cycle progression and tumorigenesis.
  • ROCK's function in proliferation and cancer may be mediated through the maintenance of cellular contractility.
  • Targeting ROCK isoforms could represent a therapeutic strategy for cancer treatment.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.3K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.5K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.9K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.7K